BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2021
View Archived Issues
New mouse model allows investigation of EP3 receptor function in the kidney tubule
Read More
Researchers identify markers of adrenomyeloneuropathy severity
Read More
NN-1213 lowers appetite and body weight in animal models of obesity
Read More
IL-33, a potential new therapeutic target for diabetic kidney disease
Read More
Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis
Read More
Jiangsu Simcere Pharmaceutical presents new SERDs
Read More
Novartis and collaborators describe new antiviral compounds
Read More
New HIF-2alpha inhibitors discovered at NiKang Therapeutics
Read More
Intarcia Therapeutics identifies new neuropeptide Y receptor agonists
Read More
Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor
Read More
Edigene and University of Wisconsin-Madison collaborate on in vivo RNA editing therapies
Read More
CN Bio and iiCON partner to validate novel organ-on-a-chip infection models for COVID-19
Read More
New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations
Read More
Spiny mice can regenerate damaged kidneys without fibrosis
Read More
HDAC8 targeting for treating AKI shows promise
Read More
Cellaria announces new products for modeling tumor microenvironment
Read More
Frequency Therapeutics unveils new research program for hearing loss and MS
Read More
Massachusetts General Hospital to conduct preclinical trial of Angany's BP/AH-01 for peanut allergy
Read More
synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells
Read More
Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs
Read More